The Motley Fool

If I Could Buy Just One Stock For Christmas, It’d Be GlaxoSmithKline plc

It has to be said, I’ve never been one to crave the “next big gadget”, or to follow the crowd when it comes to following particular trends.  But if I was to buy myself a stock as a long-overdue Christmas present to myself, I struggle to look further than one of the most popular among Fools and other investors alike – GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US).

Yes, as it’s a gift to myself I could have speculated a little and moved for a slightly sexier small-cap growth stock, but there’s one thing that the pharma giant can offer my portfolio that most of my other holdings can’t: a great dividend.  Since 2009, the dividend yield has hovered somewhere between 4.6% and 5.5%, with last year’s coming in at a very respectable 4.8%.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Now could be a good time to buy, too, in terms of the share price.  It may have seen a steady rise to just under 1,500 since its October low of 1,324, but overall, the price is still down nearly 6% over the last 6 months.  I could even consider that to be an early January bargain.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…

And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...

It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…

But you need to get in before the crowd catches onto this ‘sleeping giant’.

Click here to learn more.

Chris Nials has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

Our 6 'Best Buys Now' Shares

The renowned analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.

So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we're offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our 'no quibbles' 30-day subscription fee refund guarantee.

Simply enter your email address below to discover how you can take advantage of this.

I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement.